147 related articles for article (PubMed ID: 9580036)
1. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
[TBL] [Abstract][Full Text] [Related]
2. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Odds FC; Webster CE; Abbott AB
J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
[TBL] [Abstract][Full Text] [Related]
3. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Odds FC; Cockayne A; Hayward J; Abbott AB
J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
[TBL] [Abstract][Full Text] [Related]
4. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.
Odds FC; Webster CE
J Antimicrob Chemother; 1988 Oct; 22(4):473-81. PubMed ID: 2849601
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs].
Fan LY; Liu ZH; Bai XN; Zong X
Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287
[No Abstract] [Full Text] [Related]
6. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
[TBL] [Abstract][Full Text] [Related]
7. Synergy of lysozyme and lanoconazole on the morphology of Candida albicans.
Nishiyama Y; Nakaoka C; Hiratani T; Abe S; Uchida K; Yamaguchi H
J Electron Microsc (Tokyo); 2001; 50(1):41-9. PubMed ID: 11291959
[TBL] [Abstract][Full Text] [Related]
8. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis.
Lynch ME; Sobel JD; Fidel PL
J Med Vet Mycol; 1996; 34(5):337-9. PubMed ID: 8912167
[TBL] [Abstract][Full Text] [Related]
9. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
10. The action of miconazole of the growth of Candida albicans.
Van Den Bossche H; Willemsens G; Van Cutsem JM
Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains.
D'Auria FD; Tecca M; Strippoli R; Simonetti N
Lett Appl Microbiol; 2001 Apr; 32(4):220-3. PubMed ID: 11298929
[TBL] [Abstract][Full Text] [Related]
12. Azole resistance in Candida albicans.
Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of strains of Candida albicans to jaritin, haloprogin, clotrimazole and miconazole.
Langsadl L; Jedlickova Z
Postgrad Med J; 1979 Sep; 55(647):695-6. PubMed ID: 392487
[TBL] [Abstract][Full Text] [Related]
14. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.
Martinez-Suarez JV; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 1995 Jul; 39(7):1512-6. PubMed ID: 7492095
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
Odds FC; Cheesman SL; Abbott AB
Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.
Marriott MS
J Gen Microbiol; 1980 Mar; 117(1):253-5. PubMed ID: 6993625
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy.
Bastide M; Jouvert S; Bastide JM
Can J Microbiol; 1982 Oct; 28(10):1119-26. PubMed ID: 6295583
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
19. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
Wang FJ; Zhang D; Liu ZH; Wu WX; Bai HH; Dong HY
Chin Med J (Engl); 2016 May; 129(10):1161-5. PubMed ID: 27174323
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]